
Major US health systems expect to offer Alzheimer’s drug Leqembi in a few months
By Julie Steenhuysen and Deena Beasley CHICAGO (Reuters) – Five major U.S. health systems said they would offer Eisai and Biogen’s promising new Alzheimer’s drug Leqembi after working out payment and administrative…